In a small treatment center in the eastern Democratic Republic of the Congo, nurse Josiane Mulangu adjusts an IV drip for a patient trembling with fever—this time, it’s Bundibugyo virus, the rarest and least understood of the Ebola family. As the country battles its latest filovirus outbreak, the World Health Organization has released its first comprehensive clinical guidelines for managing all filovirus diseases, including Ebola and Marburg, offering frontline workers like Mulangu a unified, science-backed roadmap to save lives. These diseases, which have killed tens of thousands since 1967, can claim up to 90% of those infected in the most severe outbreaks. With no licensed vaccines or treatments for Marburg, Bundibugyo, or Sudan virus diseases, early supportive care is often the only lifeline. The new WHO guidelines lay out 16 evidence-based recommendations designed to standardize care, reduce complications, and improve survival—especially when treatment begins early.
The guidelines emerged from global expert consultations and draw on lessons from recent outbreaks, including the devastating 2014–2016 West Africa Ebola epidemic and the 2018–2020 Kivu outbreak in DRC. They emphasize rapid rehydration, precise use of IV fluids and vasoactive drugs to treat shock, routine monitoring for metabolic imbalances like hypoglycemia, and prompt antibiotic treatment if secondary bacterial infections are suspected. One of the most critical advances is the structured follow-up protocol for survivors, who may carry persistent virus in bodily fluids and face long-term health challenges, from joint pain to vision loss. By systematizing care from admission to recovery, the guidelines also lay the groundwork for future clinical trials of antiviral therapies—something previously hampered by inconsistent standards.
WHO Director-General Dr. Tedros Adhanom Ghebreyesus called the guidelines “a perfect example of how WHO leverages science to better protect and care for people during outbreaks and health emergencies.” The document is already being translated into French and Arabic and will be distributed to health ministries, emergency response teams, and treatment centers across at-risk regions. In DRC, where seven Ebola outbreaks have occurred since 2018, the timing couldn’t be more urgent. The new recommendations don’t just guide clinicians—they also help administrators stock essential supplies, train staff, and prepare facilities before the next outbreak strikes. As climate change, deforestation, and human encroachment increase the risk of zoonotic spillover, filoviruses are unlikely to disappear. But with these guidelines, the world is better equipped to meet them with dignity, speed, and science. The message is clear: even in the face of deadly viruses, compassionate, coordinated care can make the difference between life and death.